CAS 91032-38-1
:Teicoplanin A 2-5
Description:
Teicoplanin A2-5 is a glycopeptide antibiotic derived from the fermentation of the bacterium *Amycolatopsis orientalis*. It is primarily used for its antibacterial properties, particularly against Gram-positive bacteria, including methicillin-resistant *Staphylococcus aureus* (MRSA). The compound exhibits a complex structure characterized by a core structure of amino acids and sugar moieties, which contribute to its mechanism of action by inhibiting cell wall synthesis in bacteria. Teicoplanin A2-5 is known for its stability in the presence of various environmental conditions and has a relatively long half-life, allowing for less frequent dosing in clinical settings. It is typically administered via intravenous injection and is effective in treating serious infections, including endocarditis and skin infections. The substance is generally well-tolerated, although potential side effects may include hypersensitivity reactions and nephrotoxicity. Its use is often monitored in clinical practice to ensure efficacy and minimize adverse effects.
Formula:C89H99Cl2N9O33
InChI:InChI=1S/C89H99Cl2N9O33/c1-34(2)9-7-5-4-6-8-10-61(109)95-69-75(114)72(111)59(32-102)130-88(69)133-79-56-26-41-27-57(79)127-53-18-14-39(24-48(53)91)78(132-87-68(93-35(3)104)74(113)71(110)58(31-101)129-87)70-85(122)99-67(86(123)124)46-29-43(106)30-55(128-89-77(116)76(115)73(112)60(33-103)131-89)62(46)45-23-38(13-15-50(45)107)64(82(119)100-70)97-84(121)66(41)98-83(120)65-40-21-42(105)28-44(22-40)125-54-25-37(12-16-51(54)108)63(92)81(118)94-49(80(117)96-65)20-36-11-17-52(126-56)47(90)19-36/h11-19,21-30,34,49,58-60,63-78,87-89,101-103,105-108,110-116H,4-10,20,31-33,92H2,1-3H3,(H,93,104)(H,94,118)(H,95,109)(H,96,117)(H,97,121)(H,98,120)(H,99,122)(H,100,119)(H,123,124)/t49-,58-,59-,60-,63-,64-,65+,66-,67+,68-,69-,70+,71-,72-,73-,74-,75-,76+,77+,78-,87+,88+,89+/m1/s1
InChI key:InChIKey=FHBQKTSCJKPYIO-RLDSMAAISA-N
SMILES:O(C1=C2C([C@@H](C(O)=O)NC(=O)[C@@]3([C@H](O[C@H]4[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@@H](CO)O4)C=5C=C(Cl)C(=CC5)OC=6C=C7[C@](C(=O)N[C@](C=8C=C2C(O)=CC8)(C(=O)N3)[H])(NC(=O)[C@@]9(C=%10C=C(OC=%11C=C([C@@H](N)C(=O)N[C@@](C(=O)N9)(CC=%12C=C(Cl)C(OC(=C7)C6O[C@H]%13[C@H](NC(CCCCCCCC(C)C)=O)[C@@H](O)[C@H](O)[C@@H](CO)O%13)=CC%12)[H])C=CC%11O)C=C(O)C%10)[H])[H])[H])=CC(O)=C1)[C@H]%14O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]%14O
Synonyms:- 1H,15H,34H-20,23:30,33-Dietheno-3,18:35,48-bis(iminomethano)-4,8:10,14:25,28:43,47-tetrametheno-28H-[1,14,6,22]dioxadiazacyclooctacosino[4,5-m][10,2,16]benzoxadiazacyclotetracosine, ristomycin A aglycone deriv.
- 34-O-[2-(Acetylamino)-2-deoxy-β-<span class="text-smallcaps">D</smallcap>-glucopyranosyl]-22,31-dichloro-7-demethyl-64-O-demethyl-19-deoxy-56-O-[2-deoxy-2-[(9-methyl-1-oxodecyl)amino]-β-<smallcap>D</smallcap>-glucopyranosyl]-42-O-α-<smallcap>D</span>-mannopyranosylristomycin A aglycone
- 91032-38-1
- Ristomycin A aglycone, 34-O-[2-(acetylamino)-2-deoxy-β-<span class="text-smallcaps">D</smallcap>-glucopyranosyl]-22,31-dichloro-7-demethyl-64-O-demethyl-19-deoxy-56-O-[2-deoxy-2-[(9-methyl-1-oxodecyl)amino]-β-<smallcap>D</smallcap>-glucopyranosyl]-42-O-α-<smallcap>D</span>-mannopyranosyl-
- Teichomycin A2 factor 5
- Teichomycin A<sub>2</sub> factor 5
- Teicoplanin A 2-5
- Ristomycin A aglycone, 34-O-[2-(acetylamino)-2-deoxy-β-D-glucopyranosyl]-22,31-dichloro-7-demethyl-64-O-demethyl-19-deoxy-56-O-[2-deoxy-2-[(9-methyl-1-oxodecyl)amino]-β-D-glucopyranosyl]-42-O-α-D-mannopyranosyl-
- 34-O-[2-(Acetylamino)-2-deoxy-β-D-glucopyranosyl]-22,31-dichloro-7-demethyl-64-O-demethyl-19-deoxy-56-O-[2-deoxy-2-[(9-methyl-1-oxodecyl)amino]-β-D-glucopyranosyl]-42-O-α-D-mannopyranosylristomycin A aglycone
Sort by
The purity filter is not visible because current products do not have associated purity data for filtering.
Found 2 products.

